Our story

Innovating an Industry

Since 2012, we have been developing a solution that avoids the need for open brain surgery by using a minimally-invasive procedure.

Screen Shot 2023 03 02 at 8 57 25 AM

Quick facts about us


The device, the stentrode™, is 8mm in diameter and made from a flexible alloy called nitinol. It is inserted into Superior Sagittal Sinus in the brain via the jugular vein.


Initial grant funding was provided to a lab in the University of Melbourne by the U.S. Defense Advanced Research Projects Agency (DARPA) and Department of Defense (DoD).


In 2020, FDA awarded the stentrode™ the Breakthrough Device Designation. In 2021, Synchron became the first company to receive an FDA IDE to conduct trials of a permanently implantable BCI.


Series B funding was led by Khosla Ventures, with total capital raised now of $70M, including support from the U.S. and Australian governments.


Synchron is headquartered in Brooklyn, New York, and has an office in Melbourne, Australia.

Leadership Team

We’re a global team of scientists, innovators, and future-thinkers.

Tom Oxley CEO

Tom Oxley


5 N7 A9421 Martin Dieck Headshot Retouched Q85 2

Martin Dieck

Chairman of the Board

Nick Opie CTO

Nick Opie

Chief Innovation Officer

Employee Mocco

J Mocco

Chief Medical Officer

Thumbnail Kurt

Kurt Haggstrom

Chief Commercial Officer

Amos Meltzer CLO

Amos Meltzer

Chief Legal Officer

Connie Rey

Connie Rey

VP, Clinical Affairs

Riki Banerjee VP RD

Riki Banerjee


Gary Castro VP Finance

Gary Castro

VP, Finance

Peter Yoo Senior Director of Neuroscience

Peter Yoo

Senior Director, Neuroscience

Gil Rind Director of Advanced Technologies

Gil Rind

Senior Director, Advanced Tech


Rina Bhagat

Senior Director, Quality & Regulatory

Darragh Mc Dermott Director of Hardware

Darragh McDermott

Director, Hardware

Chloe Brown Director of Marketing

Chloe Brown

Director, Strategic Marketing

Microsoft Teams image modified

Kimberly Ha

Communications Lead





Bloomberg 50



The Best Inventions of 2021

Time Magazine


Next Big Things in Tech

Fast Company


Most Disruptive Innovator Award



Innovation Award

Society of Vascular and Neurointerventional Neurology


BCI Award

BCI Award Foundation


Innovator of the Year Finalist

Gentlemen’s Quarterly


Advance Global Overall Australian of the Year

Advance Awards


UNSW Eureka Prize for Excellence in Interdisciplinary Scientific Research

Australian Museum


Innovator of the Year Finalist

Congress of Neurological Surgeons


Khosla Ventures

Neuro Technology Investors

Metis Innovative

Martin Dieck, Chairman

Managing Member, Neuro Technology Investors

Tom Oxley

CEO, Synchron

Nick Opie

CTO, Synchron

Rahul P Sharma, MD

Director Cath Lab, Interventional Cardiology, Stanford

Alex Morgan, MD, PhD

Partner, Khosla Ventures

Ari Nowacek, MD, PhD

Principal, ARCH Venture Partners

Eddie Chang, MD

Chair, Dept of Neurosurgery UCSF

Tim Denison, PhD

Royal Academy Chair, Oxford University

Jordi Parramon, PhD

President, Google Verily

Earl Slee

VP, Medtronic (retired)

Victor Rodrigues

VP, Cochlear

Marc Slutzky, MD, PhD

Professor, Northwestern University

Josh Duyan

Investor, Artisan Partners

Max Hodak

CEO, Science (previously President at Neuralink)

Brian Martin

Founder/CEO Radical Catheter Technologies & Serial Entrepreneur

Check out our published research to learn more about our work.